NARI
Price
$55.34
Change
-$0.83 (-1.48%)
Updated
Dec 18, 04:24 PM (EDT)
76 days until earnings call
RSLS
Price
$4.63
Change
+$0.05 (+1.09%)
Updated
Dec 18, 04:18 PM (EDT)
Ad is loading...

NARI vs RSLS

Header iconNARI vs RSLS Comparison
Open Charts NARI vs RSLSBanner chart's image
Inari Medical
Price$55.34
Change-$0.83 (-1.48%)
Volume$3.9K
CapitalizationN/A
ReShape Lifesciences
Price$4.63
Change+$0.05 (+1.09%)
Volume$109
CapitalizationN/A
NARI vs RSLS Comparison Chart
Loading...
NARI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RSLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NARI vs. RSLS commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NARI is a Hold and RSLS is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (NARI: $56.16 vs. RSLS: $4.59)
Brand notoriety: NARI and RSLS are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NARI: 137% vs. RSLS: 41%
Market capitalization -- NARI: $2.74B vs. RSLS: $4.33M
NARI [@Medical Specialties] is valued at $2.74B. RSLS’s [@Medical Specialties] market capitalization is $4.33M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NARI’s FA Score shows that 0 FA rating(s) are green whileRSLS’s FA Score has 0 green FA rating(s).

  • NARI’s FA Score: 0 green, 5 red.
  • RSLS’s FA Score: 0 green, 5 red.
According to our system of comparison, both NARI and RSLS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NARI’s TA Score shows that 5 TA indicator(s) are bullish while RSLS’s TA Score has 3 bullish TA indicator(s).

  • NARI’s TA Score: 5 bullish, 4 bearish.
  • RSLS’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, NARI is a better buy in the short-term than RSLS.

Price Growth

NARI (@Medical Specialties) experienced а +2.02% price change this week, while RSLS (@Medical Specialties) price change was -8.93% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.05%. For the same industry, the average monthly price growth was +4.04%, and the average quarterly price growth was +1.94%.

Reported Earning Dates

NARI is expected to report earnings on Mar 04, 2025.

RSLS is expected to report earnings on May 15, 2023.

Industries' Descriptions

@Medical Specialties (-2.05% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NARI($2.74B) has a higher market cap than RSLS($4.33M). NARI YTD gains are higher at: -13.494 vs. RSLS (-68.307). NARI has higher annual earnings (EBITDA): 15.2M vs. RSLS (-36.72M). NARI has more cash in the bank: 115M vs. RSLS (1.45M). RSLS has less debt than NARI: RSLS (285K) vs NARI (32M). NARI has higher revenues than RSLS: NARI (494M) vs RSLS (9.81M).
NARIRSLSNARI / RSLS
Capitalization2.74B4.33M63,260%
EBITDA15.2M-36.72M-41%
Gain YTD-13.494-68.30720%
P/E Ratio344.83N/A-
Revenue494M9.81M5,038%
Total Cash115M1.45M7,937%
Total Debt32M285K11,228%
FUNDAMENTALS RATINGS
RSLS: Fundamental Ratings
RSLS
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NARIRSLS
RSI
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 8 days ago
79%
Bullish Trend 9 days ago
88%
Declines
ODDS (%)
Bearish Trend 6 days ago
77%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
NARI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RSLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TMDX65.711.49
+2.31%
TransMedics Group
AAL16.720.20
+1.21%
American Airlines Group
ATXG0.65N/A
-0.02%
Addentax Group Corp
PKST13.04-0.05
-0.38%
Peakstone Realty Trust
ZTEK1.03-0.05
-4.63%
Zentek Ltd

NARI and

Correlation & Price change

A.I.dvisor indicates that over the last year, NARI has been loosely correlated with RVTY. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if NARI jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NARI
1D Price
Change %
NARI100%
-1.04%
RVTY - NARI
46%
Loosely correlated
-0.36%
MMSI - NARI
38%
Loosely correlated
-3.24%
CSTL - NARI
31%
Poorly correlated
-2.29%
LIVN - NARI
31%
Poorly correlated
-0.42%
ICUI - NARI
30%
Poorly correlated
-1.19%
More

RSLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RSLS has been loosely correlated with GENE. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if RSLS jumps, then GENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RSLS
1D Price
Change %
RSLS100%
+2.46%
GENE - RSLS
45%
Loosely correlated
N/A
HSCS - RSLS
35%
Loosely correlated
N/A
GMED - RSLS
31%
Poorly correlated
+2.11%
NARI - RSLS
30%
Poorly correlated
-1.04%
AZTA - RSLS
30%
Poorly correlated
+4.09%
More